Debut Plus

₹1,761.9

▼ -40.74 -2.26%

17 Jul 2026

NSE Listed

Emcure Pharmaceuticals Limited (EMCURE)

Volume: 1,20,724Avg Vol 1W: 1,03,309.2Avg Vol 1M: 2,42,958.5552W Range:₹1,260₹1,944
NSE BSE www.emcure.com
Key Ratios
Checked 6h ago
Market Cap₹33,999 Cr
Current Price₹1,761.9
Previous Close₹1,802.64
High / Low (52w)₹1,944 / ₹1,260
Volume1,20,724
Avg Vol (1W)1,03,309.2
Avg Vol (1M)2,42,958.55
Stock P/E64.09
Book Value₹159.61
Dividend Yield—
ROE12.8%
ROA—
Revenue (TTM)₹7,969 Cr
Revenue Growth—
Profit Margin—
Total Debt₹190 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹16.74
P/B6.72
Debt / Equity0.49
50 DMA₹1,775.75
200 DMA₹1,554.11
Day change-2.26%
Price Chart
₹1,761.9▲ 28.65% · 1Y
₹1880₹127226.8L
2025-07-17
2026-07-16

20-day avg volume: 2.4L shares

Pros
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 64.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,815 Cr₹2,002 Cr₹1,963 Cr₹2,116 Cr₹2,101 Cr₹2,270 Cr₹2,363 Cr₹2,470 Cr
EBITDA₹266 Cr₹320 Cr₹262 Cr₹310 Cr₹321 Cr₹374 Cr₹390 Cr₹377 Cr
Net Profit₹144 Cr₹195 Cr₹154 Cr₹189 Cr₹207 Cr₹243 Cr₹231 Cr₹243 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹4,274 Cr₹4,812 Cr₹5,131 Cr₹5,067 Cr₹5,919 Cr₹6,032 Cr₹6,715 Cr₹7,969 Cr
EBITDA₹585 Cr₹577 Cr₹465 Cr₹1,000 Cr₹1,149 Cr₹967 Cr₹974 Cr₹1,158 Cr
Net Profit₹175 Cr₹195 Cr₹84 Cr₹419 Cr₹662 Cr₹532 Cr₹498 Cr₹681 Cr
EPS9.6810.794.6221.6836.6229.4227.5436.43
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹5,247 Cr₹5,644 Cr₹6,004 Cr₹6,807 Cr₹6,063 Cr₹6,673 Cr₹7,806 Cr₹8,233 Cr
Total Liabilities₹3,493 Cr₹3,744 Cr₹4,020 Cr₹4,439 Cr₹3,949 Cr₹4,023 Cr₹4,684 Cr₹3,591 Cr
Equity₹1,755 Cr₹1,900 Cr₹1,984 Cr₹2,368 Cr₹2,114 Cr₹2,650 Cr₹3,122 Cr₹4,642 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹535 Cr₹579 Cr₹592 Cr₹905 Cr₹1,079 Cr₹947 Cr₹1,321 Cr₹1,099 Cr
Investing₹-426 Cr₹-409 Cr₹-164 Cr₹-252 Cr₹-789 Cr₹-468 Cr₹-713 Cr₹-94 Cr
Financing₹-69 Cr₹-735 Cr₹-301 Cr₹-189 Cr₹-152 Cr₹-145 Cr₹-164 Cr₹-814 Cr
Free Cash Flow₹535 Cr₹579 Cr₹592 Cr₹905 Cr₹1,054 Cr₹947 Cr₹1,321 Cr₹1,099 Cr
Efficiency & Working Capital
ROCE21.8%
Interest Coverage6.5
Dividend Payout—
Debtor Days93 d
Inventory Days89 d
Payable Days68 d
Cash Conversion Cycle113 d
Working Capital Days182 d
Shareholding Details

As of 2026-03-31

Promoter77.9%
FII3.4%
DII6.1%
Institutions9.4%
Public12.7%
Promoter Pledge0%
No. of Shareholders1,22,189
Shareholding Pattern

Quarterly — figures in %. Latest 9 quarters.

PeriodJul 2024Jul 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters78.1%78.1%78.1%77.9%77.9%77.9%77.9%77.9%77.9%
FIIs1.8%1.8%2.9%3%3.1%2.9%3.3%3.6%3.4%
DIIs3.3%3%4%3.9%3.4%2.8%4.4%6.1%6.1%
Public16.8%17.2%15%15.1%15.6%16.4%14.5%12.4%12.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%
No. of Shareholders4,98,0064,98,0061,52,9141,43,4491,39,6711,33,5491,26,1691,18,8631,22,189
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Satish R MehtaShareholding of Promoter and Promoter Group39.8%7.54 Cr
Everest Trust (shares Held By Sanjay Rajanikant Mehta With Sonali Sanjay Mehta, As Trustees)Shareholding of Promoter and Promoter Group7.7%1.45 Cr
Unity Trust (shares Held By Sunil Rajanikant Mehta With Kamini Sunil Mehta, As Trustees)Shareholding of Promoter and Promoter Group7.7%1.45 Cr
Samit S MehtaShareholding of Promoter and Promoter Group7.1%1.35 Cr
Bhavana Satish MehtaShareholding of Promoter and Promoter Group4.7%89,16,888
Bc Investments Iv LimitedPublic Shareholding3.9%73,39,459
Namita Vikas ThaparShareholding of Promoter and Promoter Group2.7%50,71,200
Pushpa Rajnikant MehtaShareholding of Promoter and Promoter Group2.1%38,86,052
Sanjay Rajanikant MehtaShareholding of Promoter and Promoter Group2%37,04,028
Nippon Life India Trustee Ltd-a/c Nippon India Multi Cap FundPublic Shareholding2%36,94,528
Sunil Rajanikant MehtaShareholding of Promoter and Promoter Group1.5%28,47,012
Aditya Birla Sun Life Trustee Private Limited A/c - Aditya Birla Sun Life Elss Tax Saver FundPublic Shareholding1.3%24,85,851
Kamini Sunil MehtaShareholding of Promoter and Promoter Group0.9%16,64,960
Niraj Sunil MehtaShareholding of Promoter and Promoter Group0.6%11,00,000
Rutav Sunil MehtaShareholding of Promoter and Promoter Group0.5%9,88,224
Vikas M ThaparShareholding of Promoter and Promoter Group0.3%6,45,000
Surekha Umakant ShahShareholding of Promoter and Promoter Group0.2%3,18,216
Shah Suhasini SaumilShareholding of Promoter and Promoter Group0.1%1,29,216
Smita Paresh ShahShareholding of Promoter and Promoter Group0.1%1,07,458
Girishchandr Harrai Maganlal DesaiShareholding of Promoter and Promoter Group0.1%1,15,716
Shaila Sharad GujarShareholding of Promoter and Promoter Group0%78,206
Swati Hetalkumar ShahShareholding of Promoter and Promoter Group0%64,716
Ranjanakumari Mukeshbhai DesaiShareholding of Promoter and Promoter Group0%28,928
Shobhna DesaiShareholding of Promoter and Promoter Group0%0
Abhilasha Samit MehtaShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Satish R Mehta00%2026-03-31
Samit S Mehta00%2026-03-31
Bhavana Satish Mehta00%2026-03-31
Namita Vikas Thapar00%2026-03-31
Pushpa Rajnikant Mehta00%2026-03-31
Sanjay Rajanikant Mehta00%2026-03-31
Sunil Rajanikant Mehta00%2026-03-31
Kamini Sunil Mehta00%2026-03-31
Niraj Sunil Mehta00%2026-03-31
Rutav Sunil Mehta00%2026-03-31
Vikas M Thapar00%2026-03-31
Shah Suhasini Saumil00%2026-03-31
Board of Directors
NameDesignationYear
MUKUND KESHAO GURJARWhole Time Director2025
SUNIL RAJNIKANT MEHTAWhole Time Director2025
SATISH RAMANLAL MEHTAManaging Director & Chief Executive Officer2025
Berjis M DesaiChairman (Non-Executive)2025
NAMITA VIKAS THAPARWhole Time Director2025
P S JayakumarIndependent Director2025
Vijay GokhaleIndependent Director2025
Vidya Rajiv YeravdekarIndependent Director2025
Shailesh AyyangarIndependent Director2025
SAMIT SATISH MEHTAWhole-time Director2025
Amruta Jana YangalwarCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharmaceutical Products₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹2,350 Cr53.6%
Europe₹505 Cr11.5%
North America₹346 Cr7.9%
Other continents₹1,181 Cr27%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10250189189
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-06Board Meetings—
dividend2025-08-14₹3 (30%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253,38000934463,918
20251,03400001,034
2025000202
Company Information
Incorporated1981
ChairmanBerjis M Desai
AuditorBSR & Co LLP
Investor Email[email protected]
🌐 www.emcure.com ↗

📍 Plot # P-1 & P-2 IT BT Park, Phase II MIDC Hinjawadi, Pune, Maharashtra, 411057

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Emami LimitedEmami Paper MillsEmami Realty LimitedEMA Partners India Ltd.Embassy Office Parks REITEmbassy Developments Ltd.Electronics Mart Ind Ltd.Emkay Global Fin Serv Ltd.Emkay Tap & Cut. Tool Ltd.Emmbi Industries LimitedEnergy Mission Mach Ind LimitedEmmvee Photovoltaic Pwr LimitedAll “E” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search